A carregar...

B cells as a therapeutic target in autoimmune disease

Depleting B cells with anti-CD20 monoclonal antibodies emerges as a new therapeutic strategy in autoimmune diseases. Preliminary clinical studies suggest therapeutic benefits in patients with classic autoantibody-mediated syndromes, such as autoimmune cytopenias. Treatment responses in rheumatoid ar...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Goronzy, Jörg J, Weyand, Cornelia M
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2003
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC165047/
https://ncbi.nlm.nih.gov/pubmed/12723978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar751
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!